Overview

Detailed Summary

Cian Healthcare Limited is a WHO-GMP & ISO-9001:2015 certified company that manufactures a wide range of pharmaceutical, nutraceutical, ayurvedic, cosmeceuticals, sexual wellness, and food supplement products.
It operates under various business models including brand business, export, third-party manufacturing, and government supplies.
Cian Healthcare has developed over 1,000 formulations and 2,000 brands, indicating significant innovation and breadth in product offerings.
The company has licenses and approvals for a wide range of manufacturing services, including tablets and capsules, and conducts chemical, instrumental, and microbiology analysis.
Its manufacturing capabilities extend to producing veterinary products for major clients like SAVAvet and Venky's, showcasing its diverse operational scope.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 21 Cr
Volatility: Low Risk
P/E Ratio: -0.5
Industry P/E: 32.2
PEG Ratio: —
P/B Ratio: 0.6
52W High: 7.66
52W Low: 2.99

Sales CAGR

1Y: -50.08%
3Y: -21.61%
5Y: -11.55%
10Y: -4.63%

Profit CAGR

1Y: -3156.47%
3Y: —
5Y: —
10Y: —

ROE

TTM: -15.06%
3Y: -11.00%
5Y: -7.05%
10Y: -2.84%

ROCE

TTM: 2.17%
3Y: -3.50%
5Y: 0.56%
10Y: 6.24%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
DPL		9.33	25 Cr	22.76	0.59	0.00	3.48	6.70	1.16
ISHITADR		79.75	24 Cr	26.85	2.15	0.00	8.65	10.56	6.11
MONOPHARMA		13.30	24 Cr	7.60	0.75	0.00	2.67	6.38	0.70
VENMAX		25.60	21 Cr	23.20	2.05	0.00	4.02	3.11	6.37
CHCL		5.01	21 Cr	-0.48	0.64	0.00	-15.06	2.17	-12.46
ZENITHHE		2.99	18 Cr	33.22	2.36	0.00	-0.79	1.96	4.20
CHEMOPH		115.90	18 Cr	-12.00	12.32	0.00	-850.15	-830.59	-589.32
Median: 7 Co.	—	13.30	21 Cr	22.76	2.05	0.00	2.67	3.11	1.16

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Half Yearly Results (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024
Sales	28	39	35	47	31	38	31	33	62	19
Expenses	23	34	28	44	30	32	24	28	51	20
Interest	3.53	3.56	4.16	3.24	3.20	3.13	2.56	3.08	5.79	2.41
Operating Profit	4.19	4.97	6.83	3.34	0.91	5.48	6.90	4.46	11	-1.42
OPM %	15.14	12.78	19.60	7.12	2.94	14.47	22.47	13.68	17.62	-7.51
Other Income	0.67	-0.06	0.13	0.12	0.35	0.42	0.20	0.25	0.44	-12
Depreciation	2.84	2.24	1.22	1.79	2.48	2.71	2.72	2.72	5.47	2.43
Profit Before Tax	-1.50	-0.88	1.56	-1.57	-4.43	0.18	1.81	-1.08	0.05	-18
Tax %	-17.33	-22.73	27.56	-7.01	13.09	-166.67	14.36	-37.04	-400.00	0.00
Net Profit	-1.76	-1.08	1.13	-1.68	-3.85	0.48	1.55	-1.48	0.25	-18
EPS in Rs	—	—	—	—	—	—	—	—	—	—

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	57	74	78	69	62	31
Expenses	50	62	74	56	51	38
Operating Profit	7.25	12	4.25	12	11	-6.70
OPM %	12.70	15.99	5.46	18.05	17.61	-21.76
Other Income	0.80	0.07	0.46	0.73	0.44	-12
Interest	7.12	7.72	6.44	5.69	5.79	2.92
Depreciation	4.45	3.45	4.27	5.43	5.47	4.39
Profit Before Tax	-3.52	0.69	-6.00	1.99	0.05	-26
Tax %	-7.47	92.27	7.82	-1.94	-387.16	0.07
Net Profit	-3.79	0.05	-5.53	2.03	0.25	-26
EPS in Rs	—	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	23	23	25	25	25	25
Reserves	35	35	30	32	33	7.36
Borrowings	67	71	63	61	56	55
Other Liabilities	31	28	47	42	48	69
Total Liabilities	157	157	166	160	161	156
Fixed Assets	39	37	50	45	39	35
CWIP	25	26	13	14	15	15
Investments	4.89	4.89	4.89	4.89	4.89	4.89
Other Assets	87	90	98	97	102	101
Total Assets	157	157	166	160	161	156

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-7.31	5.93	8.58	4.84	12	21
Cash from Investing Activity	-27	2.71	1.40	2.55	-1.46	-0.25
Cash from Financing Activity	36	-9.78	-11	-7.41	-10	-3.92
Net Cash Flow	1.03	-1.13	-0.98	-0.01	-0.14	17

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2021	Mar 2022	Sep 2022	Dec 2022	Mar 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Promoters	66.26%	66.26%	66.26%	66.26%	51.85%	49.62%	27.10%	27.10%	27.10%	27.10%	27.10%	95.00%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.02%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	33.74%	33.74%	33.74%	33.73%	48.15%	50.38%	72.90%	72.90%	72.90%	72.90%	72.90%	5.00%
Total Shareholders	396	392	424	418	454	672	880	831	1,088	1,501	1,662	1,699

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Cian Healthcare Ltd

Cian Healthcare Ltd (CHCL) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Cian Healthcare Limited is a WHO-GMP & ISO-9001:2015 certified company that manufactures a wide range of pharmaceutical, nutraceutical, ayurvedic, cosmeceuticals, sexual wellness, and food supplement products. It operates under various business models including brand business, export, third-party manufacturing, and government supplies. Cian Healthcare has developed over 1,000 formulations and 2,000 brands, indicating significant innovation and breadth in product offerings. The company has licenses and approvals for a wide range of manufacturing services, including tablets and capsules, and conducts chemical, instrumental, and microbiology analysis. Its manufacturing capabilities extend to producing veterinary products for major clients like SAVAvet and Venky's, showcasing its diverse operational scope.

Over the past 52 weeks, Cian Healthcare Ltd has traded between a low of ₹2.99 and a high of ₹7.66. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Cian Healthcare Ltd has a market capitalization of approximately 20.65. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Cian Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -0.48 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 20.65 Cr, Cian Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Cian Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Cian Healthcare Ltd is -0.48. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Cian Healthcare Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Half Yearly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Cian Healthcare Ltd

What is Cian Healthcare Ltd share price today?

What does Cian Healthcare Ltd do?

What is the 52-week high and low of Cian Healthcare Ltd?

What is the market capitalization of Cian Healthcare Ltd?

Should I consider investing in Cian Healthcare Ltd stock?

Is Cian Healthcare Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Cian Healthcare Ltd belong to and why does it matter?

What is the PE ratio of Cian Healthcare Ltd?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Frequently Asked Questions about Cian Healthcare Ltd

What is Cian Healthcare Ltd share price today?

What does Cian Healthcare Ltd do?

What is the 52-week high and low of Cian Healthcare Ltd?

What is the market capitalization of Cian Healthcare Ltd?

Should I consider investing in Cian Healthcare Ltd stock?

Is Cian Healthcare Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Cian Healthcare Ltd belong to and why does it matter?

What is the PE ratio of Cian Healthcare Ltd?

Documents

Overview

Financial Ratios

Announcements

Investment Checklist

Oscillators

Neutral

Overall

Neutral

Moving Averages

Neutral

Overall

Neutral

Peers

Price Chart Comparison